Literature DB >> 3977392

Treatment of severe coagulation disturbances as a condition of improved prognosis in fulminant liver failure.

R Burghard, J U Leititis, R Rossi, R Egbring, M Brandis.   

Abstract

A favourable outcome of fulminant liver failure by replacement treatment with antithrombin III, prothrombin concentrate, fresh frozen plasma, and plasminogen is reported. Haemostatic balance was maintained and no severe bleeding complications occurred during the 15 days of disturbed liver function.

Entities:  

Mesh：

Year:  1985        PMID： 3977392      PMCID： PMC1777156          DOI： 10.1136/adc.60.2.167

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Controlled trial of exchange-transfusion therapy in fulminant hepatitis.

Authors:  A G Redeker; H S Yamahiro
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

2.  Exchange transfusion in the treatment of hepatic coma.

Authors:  M I Marks; S M Mauer; H Goldman
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

3.  Exchange transfusion in the treatment of hepatic coma.

Authors:  J S Zacarías; P Brinck; J G Huidobro
Journal:  J Pediatr       Date:  1967-11       Impact factor: 4.406

4.  Early and intensive therapy of intravascular coagulation in acute liver failure.

Authors:  M O Rake; P T Flute; K B Shilkin; M L Lewis; J Winch; R Williams
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.